menu
    • menu

    Company profile for Pharming

    NEW Drugs in Dev: 6
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Pharming is a specialty pharmaceutical company developing innovative products for the safe, effective treatment of rare diseases and unmet medical needs. We are committed to transforming the future for our patients. We develop innovative products for the treatment of unmet medical needs. Pharming’s lead product, RUCONEST® (conestat alfa) is a recombinant human C1 esterase inhibitor approved for the treatment of acute her...
    Pharming is a specialty pharmaceutical company developing innovative products for the safe, effective treatment of rare diseases and unmet medical needs. We are committed to transforming the future for our patients. We develop innovative products for the treatment of unmet medical needs. Pharming’s lead product, RUCONEST® (conestat alfa) is a recombinant human C1 esterase inhibitor approved for the treatment of acute hereditary angioedema (“HAE”) attacks in patients in Europe, the US, Israel and South Korea. The product is available on a named-patient basis in other territories where it has not yet obtained marketing authorization.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    PharmingNetherlands1 Flag
    Country
    Country
    Netherlands
    Address
    Address
    Pharming Group NV Vondellaan 47 2332 AA Leiden
    Telephone
    Telephone
    +31 (0)71 5247 400
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.pharming.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Pharming Group Files 2025 Annual Report And Form 20-F
    Pharming Group Files 2025 Annual Report And Form 20-F

    02 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/02/3267115/0/en/Pharming-Group-announces-the-filing-of-its-2025-Annual-Report-and-Form-20-F.html

    GLOBENEWSWIRE
    02 Apr 2026
    Share Share
    Pharming receives positive CHMP opinion for Joenja (leniolisib)
    Pharming receives positive CHMP opinion for Joenja (leniolisib)

    27 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/27/3263555/0/en/Pharming-Group-receives-positive-CHMP-opinion-for-Joenja-leniolisib-for-the-treatment-of-APDS-in-adult-and-pediatric-patients-12-years-and-older.html

    GLOBENEWSWIRE
    27 Mar 2026
    Share Share
    Pharming Group Approves Joenja (Leniolisib) For APDS In Japan
    Pharming Group Approves Joenja (Leniolisib) For APDS In Japan

    24 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/24/3260947/0/en/Pharming-Group-announces-approval-of-Joenja-leniolisib-in-Japan-for-the-treatment-of-APDS-in-patients-aged-4-years-and-older.html

    GLOBENEWSWIRE
    24 Mar 2026
    Share Share
    Pharming Group Achieves Strong Revenue Growth And Profitability
    Pharming Group Achieves Strong Revenue Growth And Profitability

    12 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/12/3254281/0/en/Pharming-Group-reports-fourth-quarter-and-full-year-2025-financial-results-delivering-strong-revenue-growth-and-profitability-with-positive-cash-flow.html

    GLOBENEWSWIRE
    12 Mar 2026
    Share Share
    Pharming Group Presents At Oppenheimer Healthcare Conf
    Pharming Group Presents At Oppenheimer Healthcare Conf

    17 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/17/3238948/0/en/Pharming-Group-to-present-at-the-Oppenheimer-36th-Annual-Healthcare-Life-Sciences-Conference.html

    GLOBENEWSWIRE
    17 Feb 2026
    Share Share
    Pharming Group Unveils 2026 Guidance, Rare Disease Pipeline
    Pharming Group Unveils 2026 Guidance, Rare Disease Pipeline

    03 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/03/3230713/0/en/Pharming-Group-announces-2026-financial-guidance-and-highlights-rare-disease-pipeline-at-Investor-Day.html

    GLOBENEWSWIRE
    03 Feb 2026
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search